Leaflet DAPTOMICINA ACCORDPHARMA 350mg powder for injection / infusion solution


Indicated for: bacterial infections

Route of administration: injectable / infusion

Substance: daptomycin (antibacterial antibiotic)

ATC: J01XX09 (Antiinfectives for systemic use | Other antibacterials)

Daptomycinum is an antibiotic used for the treatment of serious bacterial infections caused by Gram-positive bacteria, including skin infections, soft tissue infections, and bacteremia. It works by disrupting the bacterial cell membrane, leading to cell death.

The medication is administered intravenously and is particularly indicated for infections caused by resistant bacteria, such as methicillin-resistant Staphylococcus aureus (MRSA). It is effective in treating complicated infections.

Side effects may include muscle pain, nausea, diarrhea, and, in rare cases, rhabdomyolysis. Monitoring kidney function and creatine kinase levels during treatment is essential.

Consult your doctor before use, especially if you have kidney conditions or are taking other medications. Use Daptomycinum as directed to ensure treatment effectiveness.

General data about DAPTOMICINA ACCORDPHARMA 350mg

  • Substance: daptomycin
  • Date of last drug list: 01-02-2021
  • Commercial code: W67257001
  • Concentration: 350mg
  • Pharmaceutical form: powder for injection / infusion solution
  • Quantity: 1
  • Product type: generic
  • Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

  • Manufacturer: ACCORD HEALTHCARE LIMITED - MAREA BRITANIE
  • Holder: ACCORD HEALTHCARE POLSKA SP. Z O.O. - POLONIA
  • Number: 12970/2020/01
  • Shelf life: 2 years-after packing for marketing;after reconstitution sol.-it is used immediately

Concentrations available for daptomycin

  • 350mg
  • 500mg